Fundz

Surmount Bio, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $18 Million

PRIVATEOct 07, 2019$6M of $18M raised

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Oct 7, 2019)

Round Type

Venture

ChicagoInformation TechnologyBiotechnology

Quick answer

VANQUA BIO raised $6 Million in a funding round, dated October 7, 2019. VANQUA BIO is based in Chicago, Illinois, United States.

How much did VANQUA BIO raise?
VANQUA BIO raised $6 Million in a funding round on October 7, 2019.
What does VANQUA BIO do?
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases.
Where is VANQUA BIO based and how big is it?
VANQUA BIO is based in Chicago, Illinois, United States.
Who are the decision-makers at VANQUA BIO?
Fundz holds 1 contact at VANQUA BIO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as VANQUA BIO that raised within 45 days of this round, from Fundz verified event records.

  • VASCULAR THERAPIES INC raised $7.4M on November 21, 2019.
  • Applied Therapeutics raised $20M on November 21, 2019.
  • ILiAD Biotechnologies raised an undisclosed amount on November 20, 2019.
  • Palvella Therapeutics, Inc. raised $32M on November 20, 2019.
  • ProMIS Neurosciences raised $100K on November 20, 2019.
  • Quantum BioPharma Ltd raised $10K (Seed) on November 20, 2019.

Who to call at VANQUA BIO, and when

A new round usually means VANQUA BIO is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VANQUA BIO raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VANQUA BIO, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VANQUA BIO. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VANQUA BIO

Location

1375 W Fulton Street

Chicago, Illinois, United States

About

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VANQUA BIO raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts3 people are listed at VANQUA BIO. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VANQUA BIO's next move

See what Strategic adds

VANQUA BIO raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.